For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250313:nRSM5849Aa&default-theme=true
RNS Number : 5849A British American Tobacco PLC 13 March 2025
13 March 2025
BRITISH AMERICAN TOBACCO p.l.c. (the "Company")
Notice of Annual General Meeting 2025
The Company announces that it has published its Notice of Annual General
Meeting 2025 (the "AGM Notice 2025") on its website. Ahead of the Annual
General Meeting 2025 (the "AGM") to be held on 16 April 2025, the following
documents are being mailed and made available to its shareholders (as
applicable) today, 13 March 2025:
1) Annual Report and Form 20-F 2024 (including the Strategic Report
2024) www.bat.com/annualreport (http://www.bat.com/annualreport)
2) Combined Performance and Sustainability Summary 2024
www.bat.com/annualreport (http://www.bat.com/annualreport)
3) AGM Notice 2025 www.bat.com/AGM (http://www.bat.com/AGM)
4) Proxy Form
5) Proxy Form - South Africa
6) Voting Instruction Form - South Africa
Documents listed above with a hyperlink are also available on the Company's
website.
In compliance with UK Listing Rules 6.4.1 and 6.4.3, a copy of the following
documents will be submitted to the Financial Conduct Authority via the
National Storage Mechanism and will shortly be available for inspection via
the following link: https://data.fca.org.uk/#/nsm/nationalstoragemechanism
(https://data.fca.org.uk/#/nsm/nationalstoragemechanism) :
- The AGM Notice 2025;
- The Forms of Proxy; and
- The rules of British American Tobacco p.l.c. Performance Share
Plan 2025.
In compliance with JSE requirements and ahead of the AGM, the Company reports
that, in the case of the South Africa Branch Register, the last day to trade
is 8 April 2025 and the Record Date is 11 April 2025.
C Worlock
Assistant Secretary
Enquiries:
Investor Relations
Victoria Buxton: +44 (0)20 7845 2012 | IR_team@bat.com
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END NOASFAFFDEISEFD